Paul Sauer, SVP Process Development, Manufacturing at Vaxcyte, Inc. (PCVX), sold 6,000 shares at $25.00 ($150K) on 2021-12-29, disclosed to the SEC on 2021-12-30.
Open-market sale of $150k PCVX by SVP Process Development, Manufacturing. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PCVX | SELL | 2022-07-22 | $75K | — | Filing → |
| PCVX | SELL | 2022-05-25 | $79K | — | Filing → |
| PCVX | SELL | 2022-04-26 | $75K | — | Filing → |